As a sixth-year neurosurgery resident at Virginia Commonwealth University Medical Center, Lisa Feldman, M.D., Ph.D., aches for her patients battling aggressive brain tumors.
Despite surgery, chemotherapy and radiation treatments, the average life expectancy for patients diagnosed with glioblastoma multiforme, the most aggressive type of brain tumor, is 15 months.
“We have to do better than that,” Feldman said. “It’s so frustrating. I see so many patients suffering.”